Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
The Pharma Letter44m
FDA approves Lilly drug for obstructive sleep apnea
US pharma major Eli Lilly today announced the US Food and Drug Administration (FDA) approved Zepbound its (tirzepatide) as ...
devdiscourse39m
Wall Street Wavers Amid Federal Rate Concerns and Holiday Trading
U.S. stock markets experienced fluctuations as investors reacted to potential changes in Federal Reserve rate cuts.
S&P 500, Dow dip in choppy trading at start of holiday-shortened week
The S&P 500 and the Dow fell on Monday in holiday-thinned trading after a stopgap government funding bill averted a U.S.